Home ›
Trademark Categories ›
Pharmaceuticals ›
2015 ›
XI ›
XILORTA
Trademark search for:
XILORTA
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2015-10-12 — Application filed
2015-11-15 — Sn assigned for sect 66a appl from ib
2015-11-16 — Application filed
2015-11-20 — Application filed
2016-02-02 — Assigned to examiner
2016-02-03 — Final disposition recorded
2016-02-04 — Office action issued
2016-02-04 — Office action issued
2016-02-04 — Office action issued
2016-02-20 — Office action issued
2016-06-02 — Teas/email correspondence entered
2016-06-02 — Office action issued
2016-06-02 — Correspondence received in law office
2016-06-08 — Approved for pub - principal register
2016-06-29 — Notification of possible opposition sent to ib
2016-06-29 — Notification of notice of publication e-mailed
2016-06-29 — Notice of start of opposition period created, to be sent to ib
2016-07-19 — Published for opposition
2016-07-19 — Official gazette publication confirmation e-mailed
2016-10-04 — Registered-principal register
2016-10-12 — Notification of possible opposition - processed by ib
2017-01-04 — Final disposition recorded
2017-02-07 — Generic madrid transaction sent to ib
2017-02-07 — Generic madrid transaction created
2017-06-23 — Final disposition recorded
2021-10-04 — Courtesy reminder - sec. 71 (6-yr) e-mailed
2023-04-21 — Cancelled section 71
2023-04-21 — Final status recorded
2023-12-21 — Total invalidation of reg ext protection created
2024-01-06 — Generic madrid transaction sent to ib
2024-01-06 — Generic madrid transaction created
2024-02-05 — Total invalidation processed by the ib
Owner Information
IPSEN PHARMA S.A.S Hélène Bernard-Boyle
IPSEN PHARMA S.A.S Hélène Bernard-Boyle
IPSEN PHARMA S.A.S Hélène Bernard-Boyle
Correspondent
G MATHEW LOMBARD LOMBARD & GELIEBTER LLP
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
